
Tempest Therapeutics, Inc.
TPSTNasdaqCIK 1544227HealthcareFiscal year ends Dec 31
Reports and events: 308 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-08-1116:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106558 |
| 2025-08-1116:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106544 |
| 2025-06-1216:18 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-139899 |
| 2025-06-1107:41 ET | 8-K | 8.01 Other events | 0001193125-25-138802 |
| 2025-06-0616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-137041 |
| 2025-05-1316:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070441 |
| 2025-05-1316:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070416 |
| 2025-04-3016:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001193125-25-107127 |
| 2025-04-2809:49 ET | 8-K | 8.01 Other events | 0001193125-25-098817 |
| 2025-04-1816:16 ET | 8-K | 2.05 Exit or disposal costs | 0001193125-25-085773 |
| 2025-04-0917:26 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-076938 |
| 2025-04-0708:00 ET | 8-K | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-073987 |
| 2025-03-2716:35 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-046144 |
| 2025-03-2716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046055 |
| 2025-02-1117:58 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-018140 |
| 2024-12-3116:01 ET | 8-K | 3.01 Delisting notice | 0001193125-24-287170 |
| 2024-12-0616:15 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-272464 |
| 2024-11-1216:41 ET | DEF 14A | Proxy statementPeriod 2024-12-03 | 0001140361-24-046210 |
| 2024-11-1216:28 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125499 |
| 2024-11-1216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125444 |
| 2024-10-1007:16 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-235598 |
| 2024-08-1220:59 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-199144 |
| 2024-08-0816:44 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094124 |
| 2024-08-0816:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-094102 |
| 2024-06-2008:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-164015 |
| 2024-06-1416:41 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-161685 |
| 2024-05-1316:54 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-137304 |
| 2024-05-0916:29 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057072 |
| 2024-05-0916:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-057047 |
| 2024-04-2316:02 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001193125-24-106959 |
| 2024-03-1916:35 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-033555 |
| 2024-03-1916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-033464 |
| 2024-02-0817:41 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-028545 |
| 2023-11-0917:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-274644 |
| 2023-11-0817:25 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061278 |
| 2023-11-0817:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061271 |
| 2023-10-3006:06 ET | 8-K | 8.01 Other events | 0001193125-23-265621 |
| 2023-10-1108:13 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-253882 |
| 2023-09-0816:16 ET | 8-K | 3.01 Delisting notice | 0001193125-23-231557 |
| 2023-09-0716:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-230659 |
| 2023-08-1016:39 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041429 |
| 2023-08-1016:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-041385 |
| 2023-06-1616:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-23-169021 |
| 2023-05-1016:25 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020579 |
| 2023-05-1016:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-020569 |
| 2023-05-0116:07 ET | DEF 14A | Proxy statementPeriod 2023-06-15 | 0001193125-23-130398 |
| 2023-04-2808:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-124510 |
| 2023-03-3117:07 ET | 8-K | 8.01 Other events | 0001193125-23-088320 |
| 2023-03-2217:29 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-009237 |
| 2023-03-2217:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-009236 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.